WAT:NYE-Waters Corporation (USD)

EQUITY | Diagnostics & Research | New York Stock Exchange

Last Closing

USD 350.45

Change

0.00 (0.00)%

Market Cap

USD 10.92B

Volume

0.46M

Analyst Target

USD 210.31
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Waters Corp is an analytical instrument manufacturer. It designs, manufactures, sells and services liquid chromatography, ultra performance liquid chromatography & mass spectrometry instrument systems & support products.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-04 )

Largest Industry Peers for Diagnostics & Research

Symbol Name Price(Change) Market Cap
DHR Danaher Corporation

-1.65 (-0.83%)

USD 135.03B
A Agilent Technologies Inc

-0.26 (-0.24%)

USD 29.28B
IQV IQVIA Holdings Inc

-1.18 (-0.77%)

USD 25.66B
LH Laboratory Corporation of Amer..

-0.84 (-0.34%)

USD 18.53B
DGX Quest Diagnostics Incorporated

-0.38 (-0.21%)

USD 18.18B
QGEN Qiagen NV

-0.32 (-0.74%)

USD 8.27B
CRL Charles River Laboratories

+0.98 (+0.83%)

USD 4.90B
ENZ Enzo Biochem Inc

N/A

USD 0.02B
MTD Mettler-Toledo International I..

-8.88 (-0.81%)

N/A
TMO Thermo Fisher Scientific Inc

-1.28 (-0.30%)

N/A

ETFs Containing WAT

PHO Invesco Water Resources E.. 6.55 % 0.60 %

-0.20 (0.00%)

USD 2.04B
PIO Invesco Global Water ETF 3.62 % 0.75 %

-0.09 (0.00%)

USD 0.25B
IVEG iShares Emergent Food and.. 3.38 % 0.00 %

-0.10 (0.00%)

USD 3.84M
GSCE:SW BNP Paribas Easy Energy &.. 2.67 % 0.00 %

N/A

USD 0.13B
GSCU:SW BNP Paribas Easy Energy &.. 2.67 % 0.00 %

N/A

USD 0.10B
HLTH:AU VanEck Global Healthcare .. 2.49 % 0.00 %

+0.04 (+0.00%)

USD 0.06B
FIW First Trust Water ETF 0.00 % 0.55 %

-0.30 (0.00%)

N/A
IBB iShares Biotechnology ETF 0.00 % 0.47 %

-0.74 (0.00%)

USD 5.43B
EMEH:PA BNP Paribas Easy Energy &.. 0.00 % 0.00 %

+0.04 (+0.00%)

USD 0.08B
GSCU:PA BNP Paribas Easy Energy &.. 0.00 % 0.00 %

+0.04 (+0.00%)

USD 0.10B
EMEH:XETRA BNP Paribas Easy Energy &.. 0.00 % 0.00 %

+0.02 (+0.00%)

USD 0.11B
GSDE:XETRA BNP Paribas Easy Energy &.. 0.00 % 0.00 %

+0.10 (+0.00%)

N/A
MJJ 0.00 % 0.00 %

N/A

N/A
MJO 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Diagnostics & Research) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -5.53% 83% B 34% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -5.53% 75% C 32% F
Trailing 12 Months  
Capital Gain 9.09% 83% B 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.09% 83% B 65% D
Trailing 5 Years  
Capital Gain 92.67% 100% F 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 92.67% 100% F 66% D+
Average Annual (5 Year Horizon)  
Capital Gain 12.18% 100% F 74% C
Dividend Return 12.18% 100% F 69% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 32.00% 33% F 29% F
Risk Adjusted Return 38.06% 92% A 54% F
Market Capitalization 10.92B N/A N/A N/A N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Diagnostics & Research) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 22.60 N/A N/A
Price/Book Ratio N/A N/A N/A
Price / Cash Flow Ratio N/A N/A N/A
Price/Free Cash Flow Ratio N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A
Return on Invested Capital N/A N/A N/A
Return on Assets N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector